Review: The benefit of atypical antipsychotics over standard drugs disappears after controlling for comparator dose: Commentary

Andrew McIntosh*

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Number of pages1
JournalEvidence-based mental health
Volume4
Issue number3
DOIs
Publication statusPublished - 1 Aug 2001

Cite this